TheraMAB LLC
TheraMAB LLC Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20120219553 | USE OF A CD258 BINDING PHARMACEUTICAL SUBSTRANCE FOR MAKING A PHARMACEUTICAL COMPOSITION WITH DOSE-DEPENDENT EFFECT - The invention relates to the use of a CD28-specific superagonistic monoclonal antibody (MAB) or of a mimetic compound of the same, for producing a pharmaceutical composition, wherein the dosage is below or above a defined dosage limit. | 08-30-2012 |